Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A group of “immunological nonresponders” wants the FDA to grant them orphan disease status.
In a recent trial, the investigational entry inhibitor helped fully suppress HIV in a majority of those with multidrug-resistant virus.
Nelson Vergel pushes for the development of new salvage therapies.
In an ongoing trial of people on failing antiretroviral regimens, the injectable PRO 140 reduced viral load considerably.
Early results from an ongoing trial show that 24 weeks after adding the drug to their HIV regimen, half were virally suppressed.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.